#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acquired haemophilia Ewing's sarcoma recurrent Leiomyosarcoma metastatic Metachromatic leukodystrophy Penile cancer Fibrodysplasia ossificans progressiva Polycystic liver disease Loeys-Dietz syndrome Primary immunodeficiency syndrome Osteochondrodysplasia Deafness neurosensory Soft tissue necrosis Oropharyngeal squamous cell carcinoma Mixed-type liposarcoma Glycogen storage disease type I More trials…

    Learn about Rare Diseases

    Nephrotic syndrome – Basic Information Usher’s syndrome – Trials in Disease Glomerulonephritis rapidly progressive Primary mediastinal large B-cell lymphoma – Diagnostics Waldenstrom’s macroglobulinaemia recurrent – Trials in Disease Progressive multifocal leukoencephalopathy – Treatment Synovial sarcoma recurrent – Life with Disease Nephroblastoma – Diagnostics Haemophilia – Diagnostics Ewing’s sarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    7-Ethyl-10-Hydroxycamptothecin Rilvegostomig SULBACTAM SODIUM Follitropin Beta Epinephrine Bitartrate Timothy Grass Pollen Extract Amlitelimab OSIMERTINIB MESYLATE Salmeterol Tobramycin Ecoo15 Olorofim Rbl016.2 Gskvx000000008866 Sabirnetug Festuca Rubra Pollen AMMONIUM (15N) CHLORIDE Corline Heparin Conjugate Fluciclovine (18F) Sulfamethizole More therapies…

    Learn about Your Condition

    Acute HIV infection Paget's disease of the vulva Bipolar I disorder B-cell lymphoma recurrent Arteriovenous graft thrombosis Pericarditis Breast cancer stage IV Intestinal infarction Pyrexia Embolic stroke Colorectal cancer metastatic Testicular leiomyosarcoma Dry eye Toxic epidermal necrolysis Ventricular tachycardia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on the Effects of Sunobinop on Reducing Alcohol Consumption in Patients with Moderate to Severe Alcohol Use Disorder Seeking Treatment

    Not recruiting

    2 1
    Investigated Diseases:
    • Alcohol use disorder
    Romania

  • Study on the Effects of Venlafaxine and Gut Microbiome in Patients with Major Depressive Disorder

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • Venlafaxine
    The Netherlands

  • Study on the Effects of MM120 (Lysergide) for Adults with Generalized Anxiety Disorder

    Not recruiting

    3 1
    Investigated Diseases:
    • Generalised anxiety disorder
    Investigated Drugs:
    • LYSERGIDE
    Czechia France Germany Poland

  • Study on How N-acetylcysteine Helps Treat Cannabis Addiction in Adults

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Acetylcysteine
    Belgium

  • Study on Improving ECT Response and Reducing Cognitive Side Effects in Depression Patients Using Rivastigmine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • RIVASTIGMINE
    The Netherlands

  • Study on the Safety and Feasibility of Intravenous Hydromorphone Hydrochloride for Patients with Opioid Dependence

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • HYDROMORPHONE HYDROCHLORIDE
    Austria
Previous Page
1 … 29 30 31 32 33 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!